Cubist Systematic Strategies’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-169,781
| Closed | -$1.21M | – | 2607 |
|
|
2020
Q1 | $1.21M | Buy |
169,781
+131,371
| +342% | +$937K | 0.03% | 715 |
|
|
2019
Q4 | $917K | Buy |
38,410
+30,290
| +373% | +$723K | 0.02% | 1218 |
|
|
2019
Q3 | $218K | Sell |
8,120
-49,253
| -86% | -$1.32M | ﹤0.01% | 1735 |
|
|
2019
Q2 | $1.56M | Buy |
+57,373
| New | +$1.56M | 0.03% | 805 |
|
|
2018
Q4 | – | Sell |
-11,903
| Closed | -$317K | – | 2367 |
|
|
2018
Q3 | $317K | Sell |
11,903
-903
| -7% | -$24K | 0.02% | 1110 |
|
|
2018
Q2 | $484K | Buy |
+12,806
| New | +$484K | 0.02% | 800 |
|
|
2017
Q4 | – | Sell |
-4,039
| Closed | -$218K | – | 2191 |
|
|
2017
Q3 | $218K | Buy |
+4,039
| New | +$218K | 0.01% | 1391 |
|
|
2016
Q2 | – | Sell |
-46,878
| Closed | -$956K | – | 1963 |
|
|
2016
Q1 | $956K | Buy |
46,878
+31,105
| +197% | +$634K | 0.05% | 485 |
|
|
2015
Q4 | $812K | Buy |
+15,773
| New | +$812K | 0.05% | 576 |
|
|
2015
Q3 | – | Sell |
-7,813
| Closed | -$356K | – | 2093 |
|
|
2015
Q2 | $356K | Sell |
7,813
-5,210
| -40% | -$237K | 0.02% | 1131 |
|
|
2015
Q1 | $494K | Buy |
+13,023
| New | +$494K | 0.02% | 943 |
|